FORMULATION AND IN VIVO EVALUATION OF SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM OF RAMIPRIL IN WISTAR RATS
DOI:
https://doi.org/10.22159/ajpcr.2021.v14i7.42003Keywords:
Self-nanoemulsifying drug delivery system, Ramipril, Solubility, Ternary phase diagram, In vivo bioavailability studiesAbstract
Objective: The aim was to formulate and evaluate self-nanoemulsifying drug delivery systems (SNEDDS) of ramipril, an antihypertensive drug to improve the solubility and bioavailability.
Methods: Based on solubility studies oil phase (Sefsol 218), surfactant (Acrysol EL135), and cosurfactant (Transcutol P), respectively, were selected to prepare SNEDDS. Ramipril SNEDDS optimized employing box-Behnken design through the study of factors. All formulations were evaluated for particle size, zeta potential (ZP), polydispersity index (PDI), entrapment efficiency (EE), drug content, and in vitro drug release. The optimized formulation was characterized for Fourier transform infrared (FTIR), scanning electron microscopy (SEM), stability studies, and pharmacokinetic study.
Results: The mean particle size, PDI, ZP, EE, content uniformity, and in vitro drug release profile of optimized ramipril-loaded SNEDDS (RF14) were found to be 75.3±2.21nm, 0.126±0.05, −24.4±5.78mV, 98.74±1.97%, 99.52±1.67%, and 98.65±1.73%, respectively. FTIR studies revealed that there is no incompatibility between drug and excipients, SEM images exhibited nanoparticles to be more porous and in spherical shape. Stability studies indicated formulation was stable for 6 months. In vivo studies were conducted for optimized formulation RF14, the Tmax was found to be 0.5±0.62 and 0.5±0.95 h for the optimized and commercial formulations respectively, while Cmax was 25.16±1.73 ng/mL was significant (p<0.05) as compared to the ramipril pure drug 8.02±0.086 ng/mL. AUC0-t of the SNEDDS formulation was higher 355.49±1.76ng h/ml compared to pure drug 116.57±1.64 ng h/ml indicated higher amount of drug concentration in blood proving better systemic absorption of ramipril from SNEDDS formulation as compared to the pure drug.
Conclusion: It is concluded from the results that ramipril was successfully formulated into SNEDDS with higher concentration with fast action.
Downloads
References
O’Driscoll CM. Lipid-based formulations for intestinal lymphatic delivery. Eur J Pharm Sci 2002;15:405-15. DOI: https://doi.org/10.1016/S0928-0987(02)00051-9
Wu X, Xu J, Huang X, Wen C. Self-microemulsifying drug delivery system improves curcumin dissolution and bioavailability. Drug Dev Ind Pharm 2011;37:15-23. DOI: https://doi.org/10.3109/03639045.2010.489560
Frampton JE, Peters DH. Ramipril an updated review of its therapeutic use in essential hypertension and heart failure. Drugs 1995;49:440-66. DOI: https://doi.org/10.2165/00003495-199549030-00008
Kalhapure RS, Akamanchi KG. Oleic acid based heterolipid synthesis, characterization and application in self-microemulsifying drug delivery system. Int J Pharm 2012;425:9. DOI: https://doi.org/10.1016/j.ijpharm.2012.01.004
Yosra SR, Magda AE, Ossama YA. Self-nanoemulsifying drug delivery systems of tamoxifen citrate: Design and optimization. Int J Pharm 2009;380:133-41. DOI: https://doi.org/10.1016/j.ijpharm.2009.07.015
Brusewitz C, Schendler A, Funke A, Wagner T, Lipp R. Novel poloxamer-based nanoemulsions to enhance the intestinal absorption of active compounds. Int J Pharm 2007;329:173-81. DOI: https://doi.org/10.1016/j.ijpharm.2006.08.022
Shah SR, Parikh RH, Chavda JR. Self-nanoemulsifying drug delivery system of glimepiride: Design, development, and optimization. PDA J Pharm Sci Tech 2013;67:201-13. DOI: https://doi.org/10.5731/pdajpst.2013.00914
Wang X, Michael A, Van den Mooter G. Solid state characteristics of ternary solid dispersions composed of PVP VA64, Myrj 52 and Itraconazole. Int J Pharm 2005;303;54-61. DOI: https://doi.org/10.1016/j.ijpharm.2005.07.002
Bandivadekar MM, Pancholi SS, Shelke N. Preparation and characterization of solid SMEDDS by adsorbent techniques to improve dissolution profile of poorly aqueous soluble drug Ramipril. Int Res J Pharm 2011;2:85-90.
Ping Z, Ying L, Nianping F, Jie X. Preparation and evaluation of self-microemulsifying drug delivery system of oridonin. Int J Pharm 2008;355:269-76.
Grove M. Bioavailability of seocalcitol II: Development and characterization of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides. Eur J Pharm Sci 2004;28:233-42. DOI: https://doi.org/10.1016/j.ejps.2006.02.005
Zhang P, Liu Y, Feng N, Xu J. Preparation and evaluation of self microemulsifying drug delivery system of oridonin. Int J Pharm 2008;355:269-76. DOI: https://doi.org/10.1016/j.ijpharm.2007.12.026
Parmar K, Patel J, Sheth N. Self-nano-emulsifying drug delivery system for Embelin: Design, characterization and in-vitro studies. Asian J Pharm Sci 2015;10:396-404. DOI: https://doi.org/10.1016/j.ajps.2015.04.006
Zhang J, Peng Q, Shi S, Zhang Q, Sun X, Gong T, et al. Preparation, characterization, and in vivo evaluation of a self-nano emulsifying drug delivery system (SNEDDS) loaded with morin-phospholipid complex. Int J Nanomed 2011;6:3405-16. DOI: https://doi.org/10.2147/IJN.S25824
Basaran E, Demirel M, Sirmagul B. Cyclosporinea incorporated cationic solid lipid nanoparticles for ocular delivery. J Microencapsul 2010;27:37-47. DOI: https://doi.org/10.3109/02652040902846883
Pereira A, Gadad AP, Patil AS, Dandagi PM. Development and bioavailability assessment of ramipril nanoparticle formulation. Indian J Pharm Educ Res 2019;54:s587-95. DOI: https://doi.org/10.5530/ijper.53.4s.154
Published
How to Cite
Issue
Section
Copyright (c) 2021 Bhikshapathi D.V.R.N.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
